Close
Smartlab Europe
Inizio Ignite

STEM Healthcare appoints Jason McKenna as CEO

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Bristol Myers Evinova Partnership Targets AI-Led Trials

Bristol Myers Squibb has entered a global agreement with...

Lilly Buys Orna for $2.4bn to Advance In Vivo Therapies

Eli Lilly has agreed to acquire in vivo CAR-T...

Study Finds Fenebrutinib Cuts Disability Progression In PPMS

Roche announced late-breaking Phase III data showing that fenebrutinib...
- Advertisement -

Global benchmarking company STEM Healthcare (STEM) is pleased to announce the appointment of Jason McKenna as CEO.

Jason has been with STEM since 2010 and has held a variety of US and International roles throughout his career. Prior to joining STEM, Jason worked for AstraZeneca in the US and UK.

Commenting on his new role, Jason said, “I’m delighted to be appointed as STEM CEO at such an exciting and pivotal time for the business. I look forward to leading a very talented STEM team and engaging further with clients to ensure we continue to innovate and add value to their businesses.”

Rob Wood, President of Advisory Services said, “I’m thrilled to announce the appointment of Jason as STEM CEO. Jason founded STEM in the US and Brazil and has been a Board member for the last 6 years. He’ll bring continuity to our business so clients can be confident that STEM will go from strength to strength.

About STEM® Healthcare
STEM is a global benchmarking company that partners with 29 of the top 30 pharmaceutical companies to further accelerate performance. Working with commercial, field medical, market access and account management teams, STEM has built an industry leading benchmark database based on more than 300,000 in field observations. STEM has 7 offices globally and capabilities in >40 countries. In 2016, STEM received the prestigious Queen’s Award for Enterprise recognizing the contribution to international trade. STEM is part of Ashfield Advisory, a UDG Healthcare company. For further information visit our website at www.stemhealthcare.com

Latest stories

Related stories

Bristol Myers Evinova Partnership Targets AI-Led Trials

Bristol Myers Squibb has entered a global agreement with...

Lilly Buys Orna for $2.4bn to Advance In Vivo Therapies

Eli Lilly has agreed to acquire in vivo CAR-T...

Study Finds Fenebrutinib Cuts Disability Progression In PPMS

Roche announced late-breaking Phase III data showing that fenebrutinib...

Innovent-Lilly Partnership Expands Global Drug Development

Innovent Biologics has announced a strategic Innovent-Lilly partnership with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »